JP2016527184A5 - - Google Patents

Download PDF

Info

Publication number
JP2016527184A5
JP2016527184A5 JP2016514421A JP2016514421A JP2016527184A5 JP 2016527184 A5 JP2016527184 A5 JP 2016527184A5 JP 2016514421 A JP2016514421 A JP 2016514421A JP 2016514421 A JP2016514421 A JP 2016514421A JP 2016527184 A5 JP2016527184 A5 JP 2016527184A5
Authority
JP
Japan
Prior art keywords
group
branched
nme
och
straight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016514421A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016527184A (ja
Filing date
Publication date
Priority claimed from GB201309405A external-priority patent/GB201309405D0/en
Priority claimed from GB201402341A external-priority patent/GB201402341D0/en
Application filed filed Critical
Priority claimed from PCT/EP2014/060586 external-priority patent/WO2014187922A1/en
Publication of JP2016527184A publication Critical patent/JP2016527184A/ja
Publication of JP2016527184A5 publication Critical patent/JP2016527184A5/ja
Pending legal-status Critical Current

Links

JP2016514421A 2013-05-24 2014-05-22 Slc2a輸送体阻害剤 Pending JP2016527184A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB201309405A GB201309405D0 (en) 2013-05-24 2013-05-24 Pharmaceutical compound
GB1309405.7 2013-05-24
GB201402341A GB201402341D0 (en) 2014-02-11 2014-02-11 Pharmaceutical compound
GB1402341.0 2014-02-11
PCT/EP2014/060586 WO2014187922A1 (en) 2013-05-24 2014-05-22 Slc2a transporter inhibitors

Publications (2)

Publication Number Publication Date
JP2016527184A JP2016527184A (ja) 2016-09-08
JP2016527184A5 true JP2016527184A5 (enExample) 2017-06-29

Family

ID=50771498

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016514421A Pending JP2016527184A (ja) 2013-05-24 2014-05-22 Slc2a輸送体阻害剤

Country Status (5)

Country Link
US (1) US20160120863A1 (enExample)
EP (1) EP3004088A1 (enExample)
JP (1) JP2016527184A (enExample)
SG (1) SG11201509650YA (enExample)
WO (1) WO2014187922A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180082432A (ko) * 2015-09-29 2018-07-18 온코세라피 사이언스 가부시키가이샤 비시클릭 화합물 및 suv39h2 를 저해하기 위한 이의 용도
WO2017097671A1 (de) 2015-12-10 2017-06-15 Bayer Pharma Aktiengesellschaft Substituierte perhydropyrrolo[3,4-c]pyrrol-derivate und ihre verwendung
KR20180088462A (ko) * 2015-12-10 2018-08-03 바이엘 파마 악티엔게젤샤프트 수면-관련 호흡기 장애의 치료를 위한 TASK-1 및 TASK-2 채널의 차단제로서의 2-페닐-3-(피페라지노메틸)이미다조[1,2-a]피리딘 유도체
JOP20190005A1 (ar) * 2016-07-20 2019-01-20 Bayer Ag مركبات ديازاهيترو ثنائية الحلقة مستبدلة واستخداماتها
JOP20190284A1 (ar) * 2017-06-14 2019-12-11 Bayer Pharma AG مركبات إيميدازوبيريميدين مستبدلة بديازا ثنائي الحلقة واستخدامها للمعالجة من اضطرابات التنفس
WO2018227427A1 (en) * 2017-06-14 2018-12-20 Bayer Aktiengesellschaft Substituted bridged diazepane derivatives and use thereof
HUE066335T2 (hu) 2018-10-05 2024-07-28 Annapurna Bio Inc Vegyületek és készítmények APJ receptor aktivitáshoz kapcsolódó állapotok kezelésére
AU2019416589B2 (en) * 2018-12-29 2023-04-06 Wuhan Ll Science And Technology Development Co., Ltd. Heterocyclic compound intermediate, preparation method therefor and application thereof
JP2022108114A (ja) * 2021-01-12 2022-07-25 株式会社スタイルアンドバリュージャパン オートファジー誘導剤
WO2022233782A1 (en) 2021-05-03 2022-11-10 Lead Discovery Center Gmbh Composition comprising an inhibitor of mitochondrial transcription
CN114457045B (zh) * 2022-02-25 2023-07-14 中国人民解放军军事科学院军事医学研究院 抑制Slc2a1的RNAi腺相关病毒及其制备和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3318880A (en) * 1963-04-30 1967-05-09 Selvi & C Lab Bioterapico Novel[1, 2-alpha]imidazopyridines and a process for the manufacture thereof
FR1536351A (fr) * 1967-07-03 1968-08-27 Pyridylimidazopyridines
GB8305245D0 (en) * 1983-02-25 1983-03-30 Fujisawa Pharmaceutical Co Imidazo-heterocyclic compounds
FR2568880B1 (fr) 1984-08-07 1986-12-12 Synthelabo Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
JP2775282B2 (ja) * 1989-03-14 1998-07-16 日清製粉株式会社 紅麹の製造法
JP2003095942A (ja) * 2001-09-21 2003-04-03 Ito En Ltd 脂肪細胞におけるグルコース取込阻害剤及びglut4トランスロケーション抑制剤、筋肉細胞におけるグルコース取込活性化剤並びに脂肪軽減飲食物
FR2857966A1 (fr) * 2003-07-24 2005-01-28 Aventis Pharma Sa Produits aryl-heteroaromatiques, compositions les contenant et utilisation
JP5242885B2 (ja) * 2004-05-20 2013-07-24 株式会社 伊藤園 筋肉内ampk活性化剤
MY147647A (en) * 2005-03-21 2012-12-31 S Bio Pte Ltd Imidazo [1,2-a] pyridine derivatives : preparation and pharmaceutical applications
CA2618370A1 (en) * 2005-08-04 2007-02-15 Sirtris Pharmaceuticals, Inc. Oxazolopyridine derivatives as sirtuin modulators
EP1959959B1 (en) * 2005-12-06 2013-04-10 Merck Sharp & Dohme Corp. Morpholine carboxamide prokineticin receptor antagonists
CA2672960A1 (en) * 2006-12-20 2008-07-10 Schering Corporation Novel jnk inhibitors
EP1974729A1 (en) 2007-03-28 2008-10-01 Santhera Pharmaceuticals (Schweiz) AG Substituted imidazopyridine derivates as melanocortin- 4 receptor antagonists
CA2724842A1 (en) 2008-05-19 2009-11-26 Sunovion Pharmaceuticals Inc. Imidazo[1,2-a]pyridine compounds
EP2691392A1 (en) * 2011-03-31 2014-02-05 EMBLEM Technology Transfer GmbH Imidazo [1,2-a]pyridine compounds for use in therapy

Similar Documents

Publication Publication Date Title
JP2016527184A5 (enExample)
ES2629414T3 (es) Derivados de tiazol
JP2010504286A5 (enExample)
JP2020536863A5 (enExample)
JP2018511587A5 (enExample)
HRP20110841T1 (hr) Korisni monobaktamski antibiotici
JP2014516074A5 (enExample)
JP2006500348A5 (enExample)
JP2017511357A5 (enExample)
PE20090617A1 (es) Compuestos amino-5-[-4-(difluorometoxi)fenil]-5-fenilimidazolona para la inhibicion de -secretasa
RU2012134306A (ru) Азотосодержащие производные гетероарилов
JP2016517878A5 (enExample)
ATE537169T1 (de) Piperidin- und piperazinderivate als p2x3- antagonisten
JP2016534134A5 (enExample)
SI2824100T1 (en) 1,2,5-oxadiazoles as inhibitors of indolamine 2,3-dioxygenase
JP2019521984A5 (enExample)
JP2007519694A5 (enExample)
JP2013502423A5 (enExample)
JP2017532360A5 (enExample)
JP2015506985A5 (enExample)
JP2010510319A5 (enExample)
JP2007519695A5 (enExample)
JP2019537594A5 (enExample)
RU2006127455A (ru) Новые производные пиридина, способ их получения и содержащая их фармацевтическая композиция
JP2010510242A5 (enExample)